Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
InnoCare Pharma is a leading China-based biopharmaceutical company specializing in the research and development of innovative therapies for cancer and autoimmune diseases. The company focuses on developing high-efficacy medicines to address significant unmet medical needs on a global scale.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
InnoCare Pharma is scheduled to report its next quarterly earnings on 10/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
InnoCare Pharma last reported quarterly earnings on 8/24/2026 (Q2 2026). Earnings per share (EPS) came in at 0.09 HKD.
Across its last 3 earnings reports, InnoCare Pharma stock moved by ±3.7% on average the following day. The largest reaction was -5.3% on 04/23/2026; 1 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.